GB Patent

GB2361003A — Novel compounds

Assigned to AstraZeneca AB · Expires 2001-10-10 · 25y expired

What this patent protects

1,2,4-Triazole-3-thione compounds, processes for their preparation, pharmaceutical compositions containing them and their use in therapy in particular against autoimmune and inflammatory diseases.

USPTO Abstract

1,2,4-Triazole-3-thione compounds, processes for their preparation, pharmaceutical compositions containing them and their use in therapy in particular against autoimmune and inflammatory diseases.

Drugs covered by this patent

Patent Metadata

Patent number
GB2361003A
Jurisdiction
GB
Classification
—
Expires
2001-10-10
Drug substance claim
No
Drug product claim
No
Assignee
AstraZeneca AB
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.